Researchers examined 253 adolescents with obesity and type 2 diabetes ages 10 to 17 who underwent insulin therapy and found that elevated insulin sensitivity during randomization and therapy initiation, as well as higher adinopectin at randomization, but not beta-cell function indices, were linked to consistent improvements in A1C levels. The findings in Pediatric Diabetes "support the need for more aggressive therapy in youth with type 2 diabetes," researchers wrote.
Study IDs insulin therapy response predictors in teens with diabetes
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.